8.00% p.a. Early Redemption Worst of GOAL

Underlying: Celgene Corporation / Pfizer / UnitedHealth Group SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 40184107 / ISIN: CH0401841074

Last update 22.06.2018
  • Bid

    98.74 %
    Volume: 10'000

  • Ask

    99.74 %
    Volume: 10'000

CurrencyUSD
IssuerUBS AG, London Branch
Settlementphysical
Issue date12.02.2018
Expiry12.02.2019
Sideways return-- / --
Unit price1'000.00 USD
Underlying price1)
Celgene Corporation
Pfizer
UnitedHealth Group

78.80 USD
36.51 USD
254.37 USD
Display
  • Product chart
1) Prices are 15 Min. delayed